The Committee on Medical Affairs proposes the following amendment (SR-343.KM0001S):

Amend the bill, as and if amended, SECTION 1, by striking Section 44-29-175(A) and (B) and inserting:

 (A) Prior to administering the Pfizer-BioNTech COVID-19 vaccination, the person administering the vaccine must verbally notify the person receiving the vaccine that the vaccine is a new novel vaccine, that the vaccine is may be contaminated by the presence of fragments of bacterial plasmid DNA encapsulated in a lipid nanoparticle delivery vehicle, and that the long-term safety of the vaccine is unknown.
 (B) The person to whom the vaccine will be administered must, prior to receiving the vaccine, sign and date a written notice that states that the vaccine is a new novel vaccine, the vaccine is may be contaminated by the presence of fragments of bacterial plasmid DNA encapsulated in a lipid nanoparticle delivery vehicle, . This contamination may be hazardous to your health and the long-term safety of the vaccine is unknown.

Renumber sections to conform.

Amend title to conform.